Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by XX% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2023 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by XX% in 2023, of which the U.S. economy will grow by about XX%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2023. However, China's economic growth has slowed down. The 2023 government work report shows that the expected target of economic growth is set at about XX%.
According to research, China has set a growth rate of about XX%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2023, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
VIC Research released the 《Global Dehydrogenases Market Segment Research Report 2023》, which aims to sort out the development status and trends of the Dehydrogenases industry at home and abroad, estimate the overall market scale of the Dehydrogenases industry and the market share of major countries, Dehydrogenases industry, and study and judge the downstream market demand of Dehydrogenases through systematic research, Analyze the competition pattern of Dehydrogenases, so as to help solve the pain points of various stakeholders in Dehydrogenases industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2019-2029) of Dehydrogenases Market by VIC Research Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Dehydrogenases Market?
OYC Americas
MyBioSource
Calzyme Laboratories Inc
Syngenta AG
Novozymes A/S
Roche
TOYOBO
Changchun Huili
Randox
Major Type of Dehydrogenases Covered in VIC Research report:
Alcohol Dehydrogenase
Maltase Dehydrogenase
Others
Application Segments Covered in VIC Research Market
Food
Medicine
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Dehydrogenases Market Segment Research Report 2023
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Dehydrogenases Market by Value
2.2.1 Global Dehydrogenases Revenue by Type
2.2.2 Global Dehydrogenases Market by Value
2.3 Global Dehydrogenases Market by Sales
2.3.1 Global Dehydrogenases Sales by Type
2.3.2 Global Dehydrogenases Market by Sales
3. The Major Driver of Dehydrogenases Industry
3.1 Historical & Forecast Global Dehydrogenases Sales and Revenue (2019-2029)
3.2 Largest Application for Dehydrogenases (2019-2029)
3.3 The Major Downstream Company in China Market 2023
4. Global and Regional Dehydrogenases Market
4.1 Regional Market Size in Terms of Sales (2023 & 2029)
4.2 Regional Market Share in Terms of Revenue (2023 & 2029)
4.3 Concentration Ratio (CR5& CR10) of Dehydrogenases Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Dehydrogenases Sales (2019-2029)
5.1 Current and Estimated Sales Breakdown by Type (2019-2029)
5.2 Current and Estimated Sales Breakdown by Application (2019-2029)
5.3 Current and Estimated Revenue Breakdown by Type (2019-2029)
5.4 Current and Estimated Revenue Breakdown by Application (2019-2029)
6. Europe Dehydrogenases Sales (2019-2029)
6.1 Current and Estimated Sales Breakdown by Type (2019-2029)
6.2 Current and Estimated Sales Breakdown by Application (2019-2029)
6.3 Current and Estimated Revenue Breakdown by Type (2019-2029)
6.4 Current and Estimated Revenue Breakdown by Application (2019-2029)
7. China Dehydrogenases Sales (2019-2029)
7.1 Current and Estimated Sales Breakdown by Type (2019-2029)
7.2 Current and Estimated Sales Breakdown by Application (2019-2029)
7.3 Current and Estimated Revenue Breakdown by Type (2019-2029)
7.4 Current and Estimated Revenue Breakdown by Application (2019-2029)
8. Japan Dehydrogenases Sales (2019-2029)
8.1 Current and Estimated Sales Breakdown by Type (2019-2029)
8.2 Current and Estimated Sales Breakdown by Application (2019-2029)
8.3 Current and Estimated Revenue Breakdown by Type (2019-2029)
8.4 Current and Estimated Revenue Breakdown by Application (2019-2029)
9. India Dehydrogenases Sales (2019-2029)
9.1 Current and Estimated Sales Breakdown by Type (2019-2029)
9.2 Current and Estimated Sales Breakdown by Application (2019-2029)
9.3 Current and Estimated Revenue Breakdown by Type (2019-2029)
9.4 Current and Estimated Revenue Breakdown by Application (2019-2029)
10. Korea Dehydrogenases Sales (2019-2029)
10.1 Current and Estimated Sales Breakdown by Type (2019-2029)
10.2 Current and Estimated Sales Breakdown by Application (2019-2029)
10.3 Current and Estimated Revenue Breakdown by Type (2019-2029)
10.4 Current and Estimated Revenue Breakdown by Application (2019-2029)
11. Southeast Asia Dehydrogenases Sales (2019-2029)
11.1 Current and Estimated Sales Breakdown by Type (2019-2029)
11.2 Current and Estimated Sales Breakdown by Application (2019-2029)
11.3 Current and Estimated Revenue Breakdown by Type (2019-2029)
11.4 Current and Estimated Revenue Breakdown by Application (2019-2029)
12. South America Dehydrogenases Sales (2019-2029)
12.1 Current and Estimated Sales Breakdown by Type (2019-2029)
12.2 Current and Estimated Sales Breakdown by Application (2019-2029)
12.3 Current and Estimated Revenue Breakdown by Type (2019-2029)
12.4 Current and Estimated Revenue Breakdown by Application (2019-2029)
13. Global Dehydrogenases Average Price Trend
13.1 Market Price for Each Type of Dehydrogenases in US (2019-2023)
13.2 Market Price for Each Type of Dehydrogenases in Europe (2019-2023)
13.3 Market Price for Each Type of Dehydrogenases in China (2019-2023)
13.4 Market Price for Each Type of Dehydrogenases in Japan (2019-2023)
13.5 Market Price for Each Type of Dehydrogenases in India (2019-2023)
13.6 Market Price for Each Type of Dehydrogenases in Korea (2019-2023)
13.7 Market Price for Each Type of Dehydrogenases in Southeast Asia (2019-2023)
13.8 Market Price for Each Type of Dehydrogenases in South America (2019-2023)
14. Industrial Chain (Impact of COVID-19)
14.1 Dehydrogenases Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Dehydrogenases
15. Dehydrogenases Competitive Landscape
15.1 OYC Americas
15.1.1 OYC Americas Company Profiles
15.1.2 OYC Americas Product Introduction
15.1.3 OYC Americas Dehydrogenases Sales, Revenue (2019-2023)
15.1.4 Strategic initiatives
15.2 MyBioSource
15.2.1 MyBioSource Company Profiles
15.2.2 MyBioSource Product Introduction
15.2.3 MyBioSource Dehydrogenases Sales, Revenue (2019-2023)
15.2.4 Strategic initiatives
15.3 Calzyme Laboratories Inc
15.3.1 Calzyme Laboratories Inc Company Profiles
15.3.2 Calzyme Laboratories Inc Product Introduction
15.3.3 Calzyme Laboratories Inc Dehydrogenases Sales, Revenue (2019-2023)
15.3.4 Strategic initiatives
15.4 Syngenta AG
15.4.1 Syngenta AG Company Profiles
15.4.2 Syngenta AG Product Introduction
15.4.3 Syngenta AG Dehydrogenases Sales, Revenue (2019-2023)
15.4.4 Strategic initiatives
15.5 Novozymes A/S
15.5.1 Novozymes A/S Company Profiles
15.5.2 Novozymes A/S Product Introduction
15.5.3 Novozymes A/S Dehydrogenases Sales, Revenue (2019-2023)
15.5.4 Strategic initiatives
15.6 Roche
15.6.1 Roche Company Profiles
15.6.2 Roche Product Introduction
15.6.3 Roche Dehydrogenases Sales, Revenue (2019-2023)
15.6.4 Strategic initiatives
15.7 TOYOBO
15.7.1 TOYOBO Company Profiles
15.7.2 TOYOBO Product Introduction
15.7.3 TOYOBO Dehydrogenases Sales, Revenue (2019-2023)
15.7.4 Strategic initiatives
15.8 Changchun Huili
15.8.1 Changchun Huili Company Profiles
15.8.2 Changchun Huili Product Introduction
15.8.3 Changchun Huili Dehydrogenases Sales, Revenue (2019-2023)
15.8.4 Strategic initiatives
15.9 Randox
15.9.1 Randox Company Profiles
15.9.2 Randox Product Introduction
15.9.3 Randox Dehydrogenases Sales, Revenue (2019-2023)
15.9.4 Strategic initiatives
16. Conclusion
17. Methodology and Data Source
List of Tables and Figures
Figure 1. Total Sales by Application of Dehydrogenases Industry (Volume)
Figure 2. Dehydrogenases Sales by Regions in 2023
Figure 3. Regional Market Share in Terms of Revenue (2023&2029)
Figure 4. The Top 10 and 5 Players Market Share by Dehydrogenases Revenue in 2023
Figure 5. US Dehydrogenases Sales (2019-2029)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Dehydrogenases Sales (2019-2029)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Dehydrogenases Sales (2019-2029)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Dehydrogenases Sales (2019-2029)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Dehydrogenases Sales (2019-2029)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Dehydrogenases Sales (2019-2029)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Dehydrogenases Sales (2019-2029)
Figure 43. Current and Estimated Sales Breakdown by Type (2019-2029)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Dehydrogenases Revenue, by Type (Million USD) (2019-2029)
Table 4. Dehydrogenases Sales, by Type (K Unit) (2019-2029)
Table 5. Dehydrogenases Sales (K Unit) by Application (2019-2029)
Table 6. Dehydrogenases Sales (Million USD) by Application (2019-2029)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2023)
Table 9. Regional Market Share in Terms of Revenue (2023&2029)
Table 10. Ranking of Global Top Dehydrogenases Companies by Revenue, Concentration Ratio in 2023
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Dehydrogenases Sales (K Unit), Market Revenue (Million USD) (2019-2029)
Table 13. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 14. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 15. Current and Estimated Sales Breakdown by Application (2019-2029)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Dehydrogenases Sales (K Unit), Market Revenue (Million USD) (2019-2029)
Table 19. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 20. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 21. Current and Estimated Sales Breakdown by Application (2019-2029)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Dehydrogenases Sales (K Unit), Market Revenue (Million USD) (2019-2029)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Dehydrogenases Sales (K Unit), Market Revenue (Million USD) (2019-2029)
Table 30. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 31. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 32. Current and Estimated Sales Breakdown by Application (2019-2029)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Dehydrogenases Sales (K Unit), Market Revenue (Million USD) (2019-2029)
Table 36. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 37. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 38. Current and Estimated Sales Breakdown by Application (2019-2029)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Dehydrogenases Sales (K Unit), Market Revenue (Million USD) (2019-2029)
Table 42. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 43. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 44. Current and Estimated Sales Breakdown by Application (2019-2029)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Dehydrogenases Sales (K Unit), Market Revenue (Million USD) (2019-2029)
Table 48. Table Current and Estimated Sales Breakdown by Type (2019-2029)
Table 49. Current and Estimated Sales Breakdown by Application (2019-2029)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Dehydrogenases in US (2019-2023)
Table 53. Market Price (USD/Unit) for Each Type of Dehydrogenases in Europe (2019-2023)
Table 54. Market Price (USD/Unit) for Each Type of Dehydrogenases in China (2019-2023)
Table 55. Market Price (USD/Unit) for Each Type of Dehydrogenases in Japan (2019-2023)
Table 56. Market Price (USD/Unit) for Each Type of Dehydrogenases in India (2019-2023)
Table 57. Market Price (USD/Unit) for Each Type of Dehydrogenases in Korea (2019-2023)
Table 58. Market Price (USD/Unit) for Each Type of Dehydrogenases in Southeast Asia (2019-2023)
Table 59. Key Downstream Customer in Each Application Field
Table 60. OYC Americas Profiles
Table 61. OYC Americas Dehydrogenases Product Introduction
Table 62. OYC Americas Dehydrogenases Sales (Unit), Revenue (Million USD) (2019-2023)
Table 63. OYC Americas Strategic initiatives
Table 64. MyBioSource Profiles
Table 65. MyBioSource Dehydrogenases Product Introduction
Table 66. MyBioSource Dehydrogenases Sales (Unit), Revenue (Million USD) (2019-2023)
Table 67. MyBioSource Strategic initiatives
Table 68. Calzyme Laboratories Inc Profiles
Table 69. Calzyme Laboratories Inc Dehydrogenases Product Introduction
Table 70. Calzyme Laboratories Inc Dehydrogenases Sales (Unit), Revenue (Million USD) (2019-2023)
Table 71. Calzyme Laboratories Inc Strategic initiatives
Table 72. Syngenta AG Profiles
Table 73. Syngenta AG Dehydrogenases Product Introduction
Table 74. Syngenta AG Dehydrogenases Sales (Unit), Revenue (Million USD) (2019-2023)
Table 75. Syngenta AG Strategic initiatives
Table 76. Novozymes A/S Profiles
Table 77. Novozymes A/S Dehydrogenases Product Introduction
Table 78. Novozymes A/S Dehydrogenases Sales (Unit), Revenue (Million USD) (2019-2023)
Table 79. Novozymes A/S Strategic initiatives
Table 80. Roche Profiles
Table 81. Roche Dehydrogenases Product Introduction
Table 82. Roche Dehydrogenases Sales (Unit), Revenue (Million USD) (2019-2023)
Table 83. Roche Strategic initiatives
Table 84. TOYOBO Profiles
Table 85. TOYOBO Dehydrogenases Product Introduction
Table 86. TOYOBO Dehydrogenases Sales (Unit), Revenue (Million USD) (2019-2023)
Table 87. TOYOBO Strategic initiatives
Table 88. Changchun Huili Profiles
Table 89. Changchun Huili Dehydrogenases Product Introduction
Table 90. Changchun Huili Dehydrogenases Sales (Unit), Revenue (Million USD) (2019-2023)
Table 91. Changchun Huili Strategic initiatives
Table 92. Randox Profiles
Table 93. Randox Dehydrogenases Product Introduction
Table 94. Randox Dehydrogenases Sales (Unit), Revenue (Million USD) (2019-2023)
Table 95. Randox Strategic initiatives
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.